These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 19931363

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B, Sitthisook S, Sangwatanaroj S, Prechawat S, Songmuang SB.
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [Abstract] [Full Text] [Related]

  • 5. Epicardial left ventricular lead placement for cardiac resynchronization therapy: optimal pace site selection with pressure-volume loops.
    Dekker AL, Phelps B, Dijkman B, van der Nagel T, van der Veen FH, Geskes GG, Maessen JG.
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1641-7. PubMed ID: 15173718
    [Abstract] [Full Text] [Related]

  • 6. Survival in cardiac resynchronization therapy. What do we know?
    Préda I.
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():57-9. PubMed ID: 17584682
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C, Ometto R, Pasinato S, Finocchi G, La Vecchia L, Fontanelli A.
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Cardiac resynchronization therapy for heart failure].
    Matsuda N.
    Nihon Rinsho; 2007 May 28; 65 Suppl 5():189-94. PubMed ID: 17571383
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R, Capestro F, Misiani A, Scipione P, Georgiou D.
    Eur J Cardiovasc Prev Rehabil; 2006 Oct 28; 13(5):818-25. PubMed ID: 17001224
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M, Bonakdar HR, Jorat MV, Fazelifar AF, Alizadeh A, Ojaghi-Haghjghi Z, Esmaielzadeh M, Sadr-Ameli MA.
    Europace; 2009 Mar 28; 11(3):356-63. PubMed ID: 19136489
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.